AgingResearch.NewsJoin free

ES2

Intervention

1 paper studies it1 finding

PubChem

Across all fields, 1 paper: none in people yet

More peptides

  • In silico1

Outcomes

1

Senolytic activity

upin silico1

1 study

  1. ES2 increases senolytic activity in silico (3-7 times).

    “ES2 is considered the best senolytic candidate, as it is 3-7 times more effective than DRI.”

    In silico

    Bioinformatics procedure for investigating senolytic (anti-aging) agents: A digital signal processing technique

    Aging medicine (Milton (N.S.W))

Latest

Related